▫️Contribution ex-TAC +13%

▫️adj. EBITDA +22%

▫️adj. EBITDA-Margin of 42% on rev. & 47% on contribution ex-TAC

▫️CTV +21%

▫️Q2 Guidance:

*Contr. ex-TAC of $75-80m

*Adj. EBITDA of $40m

*Adj. EBITDA-Margin of ~50% on contr. ex-TAC